High-Throughput and Cost-Effective Sequencing Takes Center Stage

Ultima Genomics’ UG 100 Solaris™ is among the 2025 Top Innovations contest winners in the Biotechnology category.

Written byThe Scientist
| 2 min read
Conceptual green and blue image depicting gene sequencing on a black background.
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
Biotechnology

DNA sequencing technology has become a laboratory staple, helping scientists advance genomics research by leaps and bounds. However, analyzing vast amounts of genetic material often leads to bottlenecks that can impede downstream workflows and data acquisition.

Ultima Genomics’ UG 100 Solaris is a high-throughput sequencer that helps researchers overcome speed and efficiency setbacks. “Solaris technology provides the opportunity to do a sequencing run that produces over 10 billion sequencing reads,” said Jay Therrien, Ultima Genomics’ chief commercial officer. “When we came to market a little over two years ago, we talked about a $100 human genome. Just a year after commercial launch, we have reduced the price by 20 percent, so now an $80 genome, and we do that by dramatically increasing output.”

The UG 100 Solaris allows researchers to load more templates per wafer, thereby increasing output and accuracy. Kenny Beckman, director of the University of Minnesota Genomics Center, described how the platform’s stellar output and cost effectiveness have enabled the launch of the center’s Model Organism Sequencing Service (MOSS). "We deliver 30X whole-genome sequencing of Drosophila and C. elegans isolates, including a complete informatic analysis of variants, transposon insertions, and so on, for about $30. The benefit to scientists is simple, but also a bit revolutionary,” Beckman said. “Instead of using PCR plus Sanger sequencing to confirm a CRISPR edit or other genetic manipulation, you can now just sequence the entire genome, for about the same price…We think that MOSS is a great example of how a quantitative drop in cost results in a qualitative change in the way that sequencing is used."

Front and side views of Ultima Genomics’ UG 100 Sequencing Platform.

The UG 100 Sequencing Platform increases sequencing read output by over fifty percent and reduces the price per data by point by twenty percent.

Digital Creative Associates

Therrien is excited about the release of Solaris and the response of customers to the technology. “Since the time of the announcement of Solaris in February of this year, we’ve added several more commercial and academic service providers to our network, who have all been convinced of the high quality and utility of the platform and have been adding it to their range of services,” he said.

Continue reading below...

Like this story? Sign up for FREE Newsletter updates:

Latest science news storiesTopic-tailored resources and eventsCustomized newsletter content
Subscribe

Check out all of The Scientist's Top Innovation winners of 2025.

You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
Image of a woman with her hands across her stomach. She has a look of discomfort on her face. There is a blown up image of her stomach next to her and it has colorful butterflies and gut bacteria all swarming within the gut.
November 2025, Issue 1

Why Do We Feel Butterflies in the Stomach?

These fluttering sensations are the brain’s reaction to certain emotions, which can be amplified or soothed by the gut’s own “bugs".

View this Issue
Olga Anczukow and Ryan Englander discuss how transcriptome splicing affects immune system function in lung cancer.

Long-Read RNA Sequencing Reveals a Regulatory Role for Splicing in Immunotherapy Responses

Pacific Biosciences logo
Research Roundtable: The Evolving World of Spatial Biology

Research Roundtable: The Evolving World of Spatial Biology

Conceptual cartoon image of gene editing technology

Exploring the State of the Art in Gene Editing Techniques

Bio-Rad
Conceptual image of a doctor holding a brain puzzle, representing Alzheimer's disease diagnosis.

Simplifying Early Alzheimer’s Disease Diagnosis with Blood Testing

fujirebio logo

Products

Labvantage Logo

LabVantage Solutions Awarded $22.3 Million U.S Customs and Border Protection Contract to Deliver Next-Generation Forensic LIMS

The Scientist Placeholder Image

Evosep Unveils Open Innovation Initiative to Expand Standardization in Proteomics

OGT logo

OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS Panel